Patient P-01828

Synthetic patientNBL-101 · Day 119 · 55–64 · M · baseline S14Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Deteriorating

GI state

Favorable

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

26%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S14

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity+10
Toxicity+9
Nutritional resilience-7
GI instability+3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

19.5/100

worsening · +3.5 vs previous 14 d

Toxicity

Blood

16.3/100

worsening · +1.1 vs previous 14 d

Sleep quality

Wearable

45.4/100

worsening · -6.5 vs previous 14 d

Energy level

Daily log

6.4/10

stable · -0.2 vs previous 14 d

Stress level

Daily log

4.1/10

worsening · +0.2 vs previous 14 d

Steps

Wearable

4,976

worsening · -376 vs previous 14 d

Adherence

Companion

92.8 %

stable · -0.5 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 88 from the failing basin, 10 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Simple carbohydrates
-0.7no signal · 27%
Spicy / capsaicin
+0.7no signal · 20%
Alcohol
-0.5no signal · 19%
Dietary fat load
-0.4no signal · 15%
Insoluble fibre
+0.4no signal · 15%
Histamine load
+0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓45
- WearableResting HR 77 bpm
- WearableShort sleep window
Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 4.5 · butyrate capacity 62/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 67 ms
Sleep: 6.0 h
Steps: 5,004
Resting HR: 73 bpm

Daily log: GI score 20, nutritional resilience 61, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	43%	S05	AD-05	no change	90
P-01804	25%	S19	AD-05	improved	61
P-01541	24%	S09	AD-05	no change	43
P-01329	45%	S08	BR-03	improved	79
P-01677	44%	S05	BR-03	no change	86
P-01495	35%	S07	BR-03	improved	85
P-01689	26%	S13	BR-03	no change	50
P-01654	36%	S08	CR-01	improved	85
P-01430	24%	S05	CR-01	improved	54
P-01479	40%	S15	DT-01	improved	84
P-01855	35%	S04	DT-01	improved	73
P-01724	30%	S10	DT-01	improved	63